Craig Fenwick

Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


63 publications

2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2016 | 2015 | 2014 | 2012 | 2000 | 1998 | 1997 | 1996 | 1994 |
2024
Features of chronic urticaria after COVID-19 mRNA vaccine over time.
Schwab J., Foglierini M., Pescosolido E., Pacheco I., Ruiz Buendía G.A., Madelon N., Pellaton C., Banderet V., Ribi C., Bergmann M.M. et al., 2024/11/30. Communications medicine, 4 (1) p. 254. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6AC7A96117DB]
Antiviral responses induced by Tdap-IPV vaccination are associated with persistent humoral immunity to Bordetella pertussis.
Gillard J., Suffiotti M., Brazda P., Venkatasubramanian P.B., Versteegen P., de Jonge M.I., Kelly D., Bibi S., Pinto M.V., Simonetti E. et al., 2024/03/08. Nature communications, 15 (1) p. 2133. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C91442BE52F4]
A First-in-Human Randomized Study to Assess the Safety, Tolerability, Pharmacokinetics, and Neutralization Profile of Two Investigational Long-Acting Anti-SARS-CoV-2 Monoclonal Antibodies.
Moullan N., Asiago J., Stecco K., Hadi S., Albizem M., Tieu H., Hock B., Fenwick C., Lin K., Lengsfeld T. et al., 2024/01. Infectious diseases and therapy, 13 (1) pp. 173-187. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_890F055350A3]
2023
 
Broadly potent anti-SARS-CoV-2 antibody shares 93% of epitope with ACE2 and provides full protection in monkeys.
Fenwick C., Turelli P., Duhoo Y., Lau K., Herate C., Marlin R., Lamrayah M., Campos J., Esteves-Leuenberger L., Farina A. et al., 2023/12. The Journal of infection, 87 (6) pp. 524-537. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0A69FF2015C1]
Persistent humoral immune response in youth throughout the COVID-19 pandemic: prospective school-based cohort study.
Raineri A., Radtke T., Rueegg S., Haile S.R., Menges D., Ballouz T., Ulyte A., Fehr J., Cornejo D.L., Pantaleo G. et al., 2023/11/27. Nature communications, 14 (1) p. 7764. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_BDC2C0B508CE]
Lymph node dendritic cells harbor inducible replication-competent HIV despite years of suppressive ART.
Banga R., Procopio F.A., Lana E., Gladkov G.T., Roseto I., Parsons E.M., Lian X., Armani-Tourret M., Bellefroid M., Gao C. et al., 2023/10/11. Cell host & microbe, 31 (10) pp. 1714-1731.e9. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9F739E97B9B6]
Intradermal skin test with mRNA vaccines as a surrogate marker of T cell immunity in immunocompromised patients.
Fallet B., Foglierini M., Porret R., Alcaraz-Serna A., Sauvage C., Jenelten R., Caplanusi T., Gilliet M., Perez L., Fenwick C. et al., 2023/08. The Journal of infection, 87 (2) pp. 111-119. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9DA429039D3E]
Correction to: Neutrophil Activation and Immune Thrombosis Profiles Persist in Convalescent COVID‑19.
Hocini H., Wiedemann A., Blengio F., Lefebvre C., Cervantes-Gonzalez M., Foucat E., Tisserand P., Surenaud M., Coléon S., Prague M. et al., 2023/07. Journal of clinical immunology, 43 (5) p. 894. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E5F153F4367A]
Neutrophil Activation and Immune Thrombosis Profiles Persist in Convalescent COVID-19.
Hocini H., Wiedemann A., Blengio F., Lefebvre C., Cervantes-Gonzalez M., Foucat E., Tisserand P., Surenaud M., Coléon S., Prague M. et al., 2023/07. Journal of clinical immunology, 43 (5) pp. 882-893. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_30D621CDC238]
Cytokine storm complicated by cardiogenic shock induced by anti-HER2 therapies.
Godinho R., Noto A., Fenwick C., Stravodimou A., Hugelshofer S., Peters S., Hullin R., Obeid M., 2023/06. Journal for immunotherapy of cancer, 11 (6). Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D3B4F544BDF7]
Ocrelizumab Impairs the Phenotype and Function of Memory CD8+ T Cells: A 1-Year Longitudinal Study in Patients With Multiple Sclerosis.
Mathias A., Pantazou V., Perriot S., Canales M., Jones S., Oberholster L., Moulin M., Fenwick C., Bernard-Valnet R., Théaudin M. et al., 2023/03. Neurology: Neuroimmunology & Neuroinflammation, 10 (2) pp. e200084. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_53DB58799AAF]
A CD64/FcγRI-mediated mechanism hijacks PD-1 from PD-L1/2 interaction and enhances anti-PD-1 functional recovery of exhausted T cells.
Joo V., Petrovas C., de Leval L., Noto A., Obeid M., Fenwick C., Pantaleo G., 2023. Frontiers in immunology, 14 p. 1213375. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_431B1ABF3E8A]
2022
CXCL12 and CXCL13 Cytokine Serum Levels Are Associated with the Magnitude and the Quality of SARS-CoV-2 Humoral Responses.
Noto A., Joo V., Mancarella A., Suffiotti M., Pellaton C., Fenwick C., Perreau M., Pantaleo G., 2022/11/28. Viruses, 14 (12) p. 2665. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1C95F51CD2B0]
Antibodies to combat viral infections: development strategies and progress.
Pantaleo G., Correia B., Fenwick C., Joo V.S., Perez L., 2022/09. Nature reviews. Drug discovery, 21 (9) pp. 676-696. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_09F440C68729]
 
Patient-derived monoclonal antibody neutralizes SARS-CoV-2 Omicron variants and confers full protection in monkeys.
Fenwick C., Turelli P., Ni D., Perez L., Lau K., Herate C., Marlin R., Lana E., Pellaton C., Raclot C. et al., 2022/09. Nature microbiology, 7 (9) pp. 1376-1389. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_539E1A543541]
Heterogenous humoral and cellular immune responses with distinct trajectories post-SARS-CoV-2 infection in a population-based cohort.
Menges D., Zens K.D., Ballouz T., Caduff N., Llanas-Cornejo D., Aschmann H.E., Domenghino A., Pellaton C., Perreau M., Fenwick C. et al., 2022/08/18. Nature communications, 13 (1) p. 4855. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F6D33AB61943]
Active PD-L1 incorporation within HIV virions functionally impairs T follicular helper cells.
Munoz O., Banga R., Schelling R., Procopio F.A., Mastrangelo A., Nortier P., Ohmiti K., Daraspe J., Cavassini M., Fenwick C. et al., 2022/07. PLoS pathogens, 18 (7) pp. e1010673. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_BEB839579791]
Measurement of circulating CD21-CD27- B lymphocytes in SLE patients is associated with disease activity independently of conventional serological biomarkers.
Horisberger A., Humbel M., Fluder N., Bellanger F., Fenwick C., Ribi C., Comte D., 2022/06/02. Scientific reports, 12 (1) p. 9189. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_79225BAA39D6]
Humoral Responses Against Variants of Concern by COVID-19 mRNA Vaccines in Immunocompromised Patients.
Obeid M., Suffiotti M., Pellaton C., Bouchaab H., Cairoli A., Salvadé V., Stevenel C., Hottinger R., Pythoud C., Coutechier L. et al., 2022/05/01. JAMA oncology, 8 (5) pp. e220446. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8956034C5615]
Low neutralizing antibody titers after asymptomatic or non-severe SARS-CoV-2 infection over a 6-month assessment period.
Lazor-Blanchet C., Zygoura P., Dafni U., Lamoth F., Tsourti Z., Lobritz M.A., Regina J., Grandbastien B., Fenwick C., Pantaleo G. et al., 2022/05. The Journal of infection, 84 (5) pp. 722-746. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_AB5408AF350D]
High-dimensional immune phenotyping of blood cells by mass cytometry in patients infected with hepatitis C virus.
Herderschee J., Heinonen T., Fenwick C., Schrijver I.T., Ohmiti K., Moradpour D., Cavassini M., Pantaleo G., Roger T., Calandra T. et al., 2022/04. Clinical microbiology and infection, 28 (4) pp. 611.e1-611.e7. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_300AF1BADC64]
SLAMF Receptor Expression Identifies an Immune Signature That Characterizes Systemic Lupus Erythematosus.
Humbel M., Bellanger F., Horisberger A., Suffiotti M., Fluder N., Makhmutova M., Mathias A., Du Pasquier R., Fenwick C., Ribi C. et al., 2022. Frontiers in immunology, 13 p. 843059. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_439FE028F29F]
The deficiency in Th2-like Tfh cells affects the maturation and quality of HIV-specific B cell response in viremic infection.
Noto A., Suffiotti M., Joo V., Mancarella A., Procopio F.A., Cavet G., Leung Y., Corpataux J.M., Cavassini M., Riva A. et al., 2022. Frontiers in immunology, 13 p. 960120. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_3A9147719CB5]
2021
A highly potent antibody effective against SARS-CoV-2 variants of concern.
Fenwick C., Turelli P., Perez L., Pellaton C., Esteves-Leuenberger L., Farina A., Campos J., Lana E., Fiscalini F., Raclot C. et al., 2021/10/12. Cell reports, 37 (2) p. 109814. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6CC56B59453A]
68Ga-DOTATOC PET/CT to detect immune checkpoint inhibitor-related myocarditis.
Boughdad S., Latifyan S., Fenwick C., Bouchaab H., Suffiotti M., Moslehi J.J., Salem J.E., Schaefer N., Nicod-Lalonde M., Costes J. et al., 2021/10. Journal for immunotherapy of cancer, 9 (10) pp. e003594. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6D88B7F593BA]
 
Reactivation of IgA vasculitis after COVID-19 vaccination.
Obeid M., Fenwick C., Pantaleo G., 2021/09. The Lancet. Rheumatology, 3 (9) pp. e617. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1D8F6DD0B85B]
Targeting SARS-CoV-2 receptor-binding domain to cells expressing CD40 improves protection to infection in convalescent macaques.
Marlin R., Godot V., Cardinaud S., Galhaut M., Coleon S., Zurawski S., Dereuddre-Bosquet N., Cavarelli M., Gallouët A.S., Maisonnasse P. et al., 2021/09/01. Nature communications, 12 (1) p. 5215. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_90B177569A3B]
The cytokines HGF and CXCL13 predict the severity and the mortality in COVID-19 patients.
Perreau M., Suffiotti M., Marques-Vidal P., Wiedemann A., Levy Y., Laouénan C., Ghosn J., Fenwick C., Comte D., Roger T. et al., 2021/08/09. Nature communications, 12 (1) p. 4888. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D985FAB1BA6B]
A high-throughput cell- and virus-free assay shows reduced neutralization of SARS-CoV-2 variants by COVID-19 convalescent plasma.
Fenwick C., Turelli P., Pellaton C., Farina A., Campos J., Raclot C., Pojer F., Cagno V., Nusslé S.G., D'Acremont V. et al., 2021/08/04. Science translational medicine, 13 (605) pp. eabi8452. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_DB7C1B80A401]
SARS-CoV-2 seroprevalence in healthcare workers of a Swiss tertiary care centre at the end of the first wave: a cross-sectional study.
Meylan S., Dafni U., Lamoth F., Tsourti Z., Lobritz M.A., Regina J., Bressin P., Senn L., Grandbastien B., Andre C. et al., 2021/07/05. BMJ open, 11 (7) pp. e049232. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_471F833F0211]
 
Acquisition of optimal TFH cell function is defined by specific molecular, positional, and TCR dynamic signatures.
Padhan K., Moysi E., Noto A., Chassiakos A., Ghneim K., Perra M.M., Shah S., Papaioannou V., Fabozzi G., Ambrozak D.R. et al., 2021/05/04. Proceedings of the National Academy of Sciences of the United States of America, 118 (18) pp. e2016855118. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4A4C000AF4D9]
A Randomized Placebo-Controlled Efficacy Study of a Prime Boost Therapeutic Vaccination Strategy in HIV-1-Infected Individuals: VRI02 ANRS 149 LIGHT Phase II Trial.
Lévy Y., Lacabaratz C., Lhomme E., Wiedemann A., Bauduin C., Fenwick C., Foucat E., Surenaud M., Guillaumat L., Boilet V. et al., 2021/04/12. Journal of virology, 95 (9) pp. e02165-20. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6673B3848E48]
In Situ Characterization of Follicular Helper CD4 T Cells Using Multiplexed Imaging.
Ioannidou K., Ndiaye D.R., Noto A., Fenwick C., Fortis S.P., Pantaleo G., Petrovas C., de Leval L., 2021/02/28. Frontiers in immunology, 11 p. 607626. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0018D6BF0D49]
Personalized Cytokine-Directed Therapy With Tocilizumab for Refractory Immune Checkpoint Inhibitor-Related Cholangiohepatitis.
Moi L., Bouchaab H., Mederos N., Nguyen-Ngoc T., Perreau M., Fenwick C., Vaucher J., Sempoux C., Peters S., Obeid M., 2021/02. Journal of thoracic oncology, 16 (2) pp. 318-326. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_3FFE3BA356BB]
Changes in SARS-CoV-2 Spike versus Nucleoprotein Antibody Responses Impact the Estimates of Infections in Population-Based Seroprevalence Studies.
Fenwick C., Croxatto A., Coste A.T., Pojer F., André C., Pellaton C., Farina A., Campos J., Hacker D., Lau K. et al., 2021/01/13. Journal of virology, 95 (3) pp. e01828-20. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_95BA21CCB9C1]
Case Report: Stepwise Anti-Inflammatory and Anti-SARS-CoV-2 Effects Following Convalescent Plasma Therapy With Full Clinical Recovery.
Zimmerli A., Monti M., Fenwick C., Eckerle I., Beigelman-Aubry C., Pellaton C., Jaton K., Dumas D., Stamm G.M., Infanti L. et al., 2021. Frontiers in immunology, 12 p. 613502. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_AE27E1EE2E3C]
Restoration of NK Cell Cytotoxic Function With Elotuzumab and Daratumumab Promotes Elimination of Circulating Plasma Cells in Patients With SLE.
Humbel M., Bellanger F., Fluder N., Horisberger A., Suffiotti M., Fenwick C., Ribi C., Comte D., 2021. Frontiers in immunology, 12 p. 645478. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_27C3800011DA]
2020
 
Cytokine-directed therapy with tocilizumab for immune checkpoint inhibitor-related hemophagocytic lymphohistiocytosis.
Özdemir B.C., Latifyan S., Perreau M., Fenwick C., Alberio L., Waeber G., Spertini F., de Leval L., Michielin O., Obeid M., 2020/12. Annals of oncology, 31 (12) pp. 1775-1778. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DC85C792AD0C]
BCG Vaccination Induces Long-Term Functional Reprogramming of Human Neutrophils.
Moorlag SJCFM, Rodriguez-Rosales Y.A., Gillard J., Fanucchi S., Theunissen K., Novakovic B., de Bont C.M., Negishi Y., Fok E.T., Kalafati L. et al., 2020/11/17. Cell reports, 33 (7) p. 108387. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7370314447E5]
TLR-9 agonist and CD40-targeting vaccination induces HIV-1 envelope-specific B cells with a diversified immunoglobulin repertoire in humanized mice.
Godot V., Tcherakian C., Gil L., Cervera-Marzal I., Li G., Cheng L., Ortonne N., Lelièvre J.D., Pantaleo G., Fenwick C. et al., 2020/11. PLoS pathogens, 16 (11) pp. e1009025. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_772249C57318]
2019
Structural Basis for Broad HIV-1 Neutralization by the MPER-Specific Human Broadly Neutralizing Antibody LN01.
Pinto D., Fenwick C., Caillat C., Silacci C., Guseva S., Dehez F., Chipot C., Barbieri S., Minola A., Jarrossay D. et al., 2019/11/13. Cell host & microbe, 26 (5) pp. 623-637.e8. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_EBC683B64355]
T-cell exhaustion in HIV infection.
Fenwick C., Joo V., Jacquier P., Noto A., Banga R., Perreau M., Pantaleo G., 2019/11. Immunological reviews, 292 (1) pp. 149-163. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_09E2A0F1A53D]
Development of a novel human phage display-derived anti-LAG3 scFv antibody targeting CD8+ T lymphocyte exhaustion
Ascione A., Arenaccio C., Mallano A., Flego M., Gellini M., Andreotti M., Fenwick C., Pantaleo G., Vella S., Federico M., 2019/10/17. BMC biotechnology, 19 (1) p. 67. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_712A491B51BD]
Lymph node migratory dendritic cells modulate HIV-1 transcription through PD-1 engagement.
Banga R., Rebecchini C., Procopio F.A., Noto A., Munoz O., Ioannidou K., Fenwick C., Ohmiti K., Cavassini M., Corpataux J.M. et al., 2019/07. PLoS pathogens, 15 (7) pp. e1007918. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1FF4BBBC8958]
Tumor suppression of novel anti-PD-1 antibodies mediated through CD28 costimulatory pathway.
Fenwick C., Loredo-Varela J.L., Joo V., Pellaton C., Farina A., Rajah N., Esteves-Leuenberger L., Decaillon T., Suffiotti M., Noto A. et al., 2019/07/01. The Journal of experimental medicine, 216 (7) pp. 1525-1541. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0B420592FE76]
 
PERISCOPE: road towards effective control of pertussis.
PERISCOPE Consortium, Diavatopoulos D.A., 2019/05. The Lancet. Infectious diseases, 19 (5) pp. e179-e186. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3850F0D40112]
2018
CD32+ and PD-1+ Lymph Node CD4 T Cells Support Persistent HIV-1 Transcription in Treated Aviremic Individuals
Noto A., Procopio F.A., Banga R., Suffiotti M., Corpataux J.M., Cavassini M., Riva A., Fenwick C., Gottardo R., Perreau M. et al., 2018/10/15. Journal of virology, 92 (20). Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_EFF772664CD3]
Sensitive and frequent identification of high avidity neo-epitope specific CD8 + T cells in immunotherapy-naive ovarian cancer.
Bobisse S., Genolet R., Roberti A., Tanyi J.L., Racle J., Stevenson B.J., Iseli C., Michel A., Le Bitoux M.A., Guillaume P. et al., 2018/03/15. Nature communications, 9 (1) p. 1092. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_10AE95ADCEE8]
Comparison of CyTOF assays across sites: Results of a six-center pilot study.
Leipold M.D., Obermoser G., Fenwick C., Kleinstuber K., Rashidi N., McNevin J.P., Nau A.N., Wagar L.E., Rozot V., Davis M.M. et al., 2018/02. Journal of immunological methods, 453 pp. 37-43. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_52B838044D38]
2016
Impact of the microbial derived short chain fatty acid propionate on host susceptibility to bacterial and fungal infections in vivo.
Ciarlo E., Heinonen T., Herderschee J., Fenwick C., Mombelli M., Le Roy D., Roger T., 2016/11/29. Scientific reports, 6 p. 37944. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CB627C7BE2E8]
 
Aligning Potency and Pharmacokinetic Properties for Pyridine-Based NCINIs.
Fader L.D., Bailey M., Beaulieu E., Bilodeau F., Bonneau P., Bousquet Y., Carson R.J., Chabot C., Coulombe R., Duan J. et al., 2016/08/11. ACS medicinal chemistry letters, 7 (8) pp. 797-801. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B41692B43668]
2015
 
Emerging single-cell technologies in immunology.
Herderschee J., Fenwick C., Pantaleo G., Roger T., Calandra T., 2015. Journal of Leukocyte Biology, 98 (1) pp. 23-32. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B577FB613E4C]
2014
 
Minimizing the Contribution of Enterohepatic Recirculation to Clearance in Rat for the NCINI Class of Inhibitors of HIV.
Fader L.D., Carson R., Morin S., Bilodeau F., Chabot C., Halmos T., Bailey M.D., Kawai S.H., Coulombe R., Laplante S. et al., 2014/06/12. ACS medicinal chemistry letters, 5 (6) pp. 711-716. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5CE666E444A8]
 
Preclinical profile of BI 224436, a novel HIV-1 non-catalytic-site integrase inhibitor.
Fenwick C., Amad M., Bailey M.D., Bethell R., Bös M., Bonneau P., Cordingley M., Coulombe R., Duan J., Edwards P. et al., 2014/06. Antimicrobial agents and chemotherapy, 58 (6) pp. 3233-3244. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B102A26D21AA]
 
Discovery of BI 224436, a Noncatalytic Site Integrase Inhibitor (NCINI) of HIV-1.
Fader L.D., Malenfant E., Parisien M., Carson R., Bilodeau F., Landry S., Pesant M., Brochu C., Morin S., Chabot C. et al., 2014/04/10. ACS medicinal chemistry letters, 5 (4) pp. 422-427. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F1EE56BC58BC]
 
Human rhinovirus VPg uridylylation AlphaScreen for high-throughput screening.
Gingras R., Mekhssian K., Fenwick C., White P.W., Thibeault D., 2014/02. Journal of biomolecular screening, 19 (2) pp. 259-269. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_946F9F90D33E]
2012
 
A high-throughput assay for HIV-1 integrase 3'-processing activity using time-resolved fluorescence.
Han Y.S., Quashie P., Mesplede T., Xu H., Mekhssian K., Fenwick C., Wainberg M.A., 2012/09. Journal of virological methods, 184 (1-2) pp. 34-40. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_748D64348F6D]
2000
 
A subclass of Ras proteins that regulate the degradation of IkappaB.
Fenwick C., Na S.Y., Voll R.E., Zhong H., Im S.Y., Lee J.W., Ghosh S., 2000/02/04. Science, 287 (5454) pp. 869-873. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1DB54119C1DF]
1998
 
Study of Oxyferryl Heme Reactivity Using Both Radiation and Photochemical Techniques
English A. M., Fox T., Tsaprailis G., Fenwick C. W., Wishart J. F., Hazzard J. T., Tollin G., 1998/04/17. pp. 81-98 dans Advances in Chemistry, American Chemical Society.
[DOI][serval:BIB_2FF54CC0CADE]
1997
 
pH and Driving Force Dependence of Intramolecular Oxyferryl Heme Reduction in Myoglobin
Fenwick Craig W., English Ann M., Wishart James F., 1997/05/01. Journal of the American Chemical Society, 119 (20) pp. 4758-4764.
[DOI][WoS][serval:BIB_44B341D6E347]
1996
 
Local stabilities of horse cytochrome c metalloderivatives as probed by tryptic digestion and electrospray mass spectrometry
Hu Yazhen, Fenwick Craig, English Ann M., 1996/02. Inorganica Chimica Acta, 242 (1-2) pp. 261-269.
[DOI][serval:BIB_587AE543BBA1]
 
Trapping and LC−MS Identification of Protein Radicals Formed in the Horse Heart Metmyoglobin−H<sub>2</sub>O<sub>2</sub> Reaction
Fenwick Craig W., English Ann M., 1996/01/01. Journal of the American Chemical Society, 118 (48) pp. 12236-12237.
[DOI][WoS][serval:BIB_678CAA64FDC0]
1994
 
Rate of Intramolecular Reduction of Oxyferryl Iron in Horse Heart Myoglobin
Fenwick Craig, Marmor Stephen, Govindaraju K., English Ann M., Wishart James F., Sun Ji, 1994/04. Journal of the American Chemical Society, 116 (7) pp. 3169-3170.
[DOI][WoS][serval:BIB_8C38278CE3B2]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University